CPT code 68200 – Subconjunctival injection billing guide

Key takeaways

CPT Code 68200 covers the subconjunctival injection itself, and the drug is billed separately with its own HCPCS J-code on the same claim.

Medicare lists a bilateral indicator of 1 for 68200, so injecting both eyes on one date pays 150% of the single-eye amount.

68200 and 67028 are different procedures at different depths in the eye, so one code must never be substituted for the other.

NCCI edits bundle 68200 into cataract and intraocular surgery codes 66820-66986, and a modifier can unbundle it only for a distinct, documented service.

Pabau, the practice management platform we build, scrubs each claim for missing or invalid details and flags it before submission.

CPT Code 68200: Definition and official descriptor

CPT Code 68200 is the AMA code for subconjunctival injection, which places a drug in the loose tissue between the bulbar conjunctiva and the sclera. It sits within the Eye and Ocular Adnexa section (65091-68899) of Surgery, in the Conjunctiva subsection.

One unit of service equals one injection event per eye. The code pays for the injection only. The drug is billed separately on the same claim with its HCPCS Level II J-code, under standard Medicare Part B drug rules.

Don’t be thrown by the CMS fee schedule files, which give 68200 the short descriptor “Treat eyelid by injection.” The procedure targets the conjunctiva, not the eyelid, and the AMA descriptor is the one to code from.

What the subconjunctival injection procedure involves

A subconjunctival injection places medication in the loose tissue beneath the conjunctiva. From there the drug diffuses into the front of the eye and, to a lesser extent, the back. The physician instills a topical anesthetic first, then injects at the limbus or in the inferior fornix with a fine-gauge needle.

The anatomy decides the code. The subconjunctival space sits above the sclera, entirely outside the globe. In CPT 67028 the needle enters the vitreous cavity inside the eye instead. Billing 67028 for a drug delivered subconjunctivally, or the reverse, misstates the procedure on the claim. The diagram below shows how far each eye procedure code reaches.

Commonly reported diagnoses include conjunctivitis (H10.xx), keratitis and corneal ulcer (H16.xx), and iridocyclitis or anterior uveitis (H20.xx). Coverage depends on the payer’s policy. For a planned post-operative injection, report the operative eye condition as the primary diagnosis.

Commonly reported diagnoses for 68200

Payers want a diagnosis that supports an injection, not one that only describes eye symptoms. Which diagnoses they accept depends on each payer’s policy. Cosmetic diagnoses, unexplained eye pain, and a diagnosis that doesn’t match the treated eye will draw a denial.

Modifiers for 68200 claims

Modifiers on 68200 tell the payer which eye was treated and whether the injection stands apart from other same-day procedures. Each one below needs documentation that matches it, or it becomes a compliance risk.

How to bill bilateral subconjunctival injections

CPT Code 68200 carries a bilateral surgery indicator of 1 in the CY2026 Medicare Physician Fee Schedule. When both eyes are injected on the same date, Medicare pays 150% of the single-eye amount rather than 200%.

How the claim lines look depends on your Medicare administrative contractor (MAC) and the payer:

• One line: 68200-50 with 1 unit, which many MACs ask for on bilateral-indicator-1 codes
• Two lines: 68200-RT and 68200-LT with 1 unit each, where the MAC or payer asks for that format instead
• Drug lines: the J-code for each eye’s dose on its own line, with units that match the note
• Diagnosis: a bilateral ICD-10-CM code, or a separate laterality code for each eye

Some commercial payers set their own bilateral format and payment rules. Sending two lines to a payer that expects -50 usually ends with one line paid and the other denied as a duplicate. Check the payer contract and build the format into your claim template before the first submission.

Drug billing: J-codes to report alongside 68200

68200 pays for the injection, not the drug. Report the drug on its own line with the correct HCPCS Level II J-code, with units that match the dose given.

Triamcinolone is the easiest drug to get wrong on units. J3301 counts in 10 mg units, while the preservative-free J3300 counts every milligram. Pick the code from the vial in your stock, then calculate the units.

Medicare Part B lets you bill the unused part of a single-dose vial as wastage with the JW modifier on the drug line. Document the discarded amount and that it couldn’t be used for another patient. When nothing is discarded from a single-dose container, add the JZ modifier to the drug line instead.

Medicare routinely requests invoices for J3490 claims, so keep supplier invoices in your billing records.

NCCI edits and bundling rules

The National Correct Coding Initiative (NCCI) publishes procedure-to-procedure edits listing code pairs that Medicare won’t pay separately on the same date. Check the current edit table before combining 68200 with other same-day codes. The tables change every quarter, so a pair that paid last year may be bundled today.

The edit that catches most practices is surgical. NCCI bundles 68200 into cataract and intraocular surgery codes 66820 through 66986, including 66984. Those pairs carry a modifier indicator of 1, so a modifier can unbundle the injection only when it is a distinct, documented service.

Intravitreal injection, billed with 67028, is a separate procedure at a different depth. The two codes describe different services, so one must never be substituted for the other. Reporting 67028 for a drug placed under the conjunctiva misstates the service on the claim.

• Evaluation and management (E/M) codes: An E/M code on the same date as 68200 is payable when the note documents a separate medical decision. That decision must go beyond the choice to inject. Append modifier -25 to the E/M code, and make sure the note shows the distinct service.
• Nerve block codes (e.g., 64400): NCCI may bundle certain local or regional anesthetic injections with 68200 on the same date. Verify the current edit table before billing both. Modifier -59 may apply when the nerve block is a separate, documented service.
• Anesthesia codes: Monitored anesthesia care in a facility follows separate CMS reporting rules. The anesthesiologist usually bills it, not the ophthalmologist.

Neighboring codes: how 68200 differs from related eye procedures

Anatomical location decides the correct code, not the drug used or the condition treated. Swapping 67028 and 68200 misreports the procedure, and payers don’t treat it as a clerical slip.

Medicare and payer reimbursement for CPT Code 68200

Medicare pays 68200 at different rates by place of service. The non-facility rate applies in the physician’s office. The lower facility rate applies in an ambulatory surgical center or hospital outpatient department, where the facility bills its own fee.

These figures come from the October 2026 CMS RVU file and are national amounts before geographic adjustment. Your MAC’s locality rate will differ, so confirm it in the CMS Physician Fee Schedule lookup tool before you quote a figure.

Medicare Part B pays for the drug at Average Sales Price (ASP) plus 6%, before the sequestration reduction. The rate comes from the most recent quarterly ASP file. For drugs billed under J3490, Medicare may ask for proof of the acquisition cost.

Run an insurance eligibility verification before the injection date to confirm the plan covers the drug under the patient’s medical benefit. That check matters most for high-cost agents that need prior authorization.

Commercial payer rates for 68200 vary widely from Medicare’s. Some payers pay a multiple of the Medicare rate, while others use their own relative value scales. Confirm 68200 reimbursement in your payer contract, then reconcile the remittance advice against it once payment posts.

Documentation requirements for 68200 claims

Incomplete documentation is a frequent cause of 68200 denials. Build these five elements into the injection note template as structured fields, so coders can confirm each one before the claim leaves the practice.

1. Medical necessity statement: The note must say why a subconjunctival injection was chosen over topical or systemic therapy. Auditors look for the link between the diagnosis and the decision to inject.
2. Drug identification: Record the drug name, formulation, strength, dose, route (subconjunctival), and lot number. These details must match the J-code and unit count on the claim.
3. Laterality: State which eye was treated: left, right, or both. The eye documented must match the modifier on the claim line.
4. Post-injection monitoring: Note that the patient was observed after the injection. Record any immediate reaction, such as pain, chemosis, or subconjunctival hemorrhage.
5. Informed consent: Some payers and state regulations require documented consent for injection procedures. Keep a signed consent form in the patient record and reference it in the clinical note.

A clean claim for 68200 passes three checks on its first submission:

• The ICD-10-CM code is at the highest specificity available.
• The J-code units match the documented dose.
• The eye modifier matches the laterality in the note.

Common denial reasons and how to appeal them

Most 68200 denials are preventable, and each reason below has a fix at the front end. The remittance shows a claim adjustment reason code (CARC) for every denial. Our guide to medical billing denial codes explains what each one means.

• Wrong code submitted (67028 vs. 68200): The operative report or clinical note must document the injection site. Appeal with the original note showing subconjunctival placement, plus an attestation letter if the note was ambiguous.
• Non-matching or absent ICD-10-CM code: The diagnosis doesn’t support an injection, or it is missing. Correct it to the most specific code available. Resubmit with an amended note if the original left out the clinical reason.
• NCCI bundling conflict without modifier -59: Bundled codes were billed on the same date without documented distinct services. Find the triggering NCCI edit pair, check the note for a separate service, and appeal with the note and a written explanation.
• Bilateral submission error: Two RT and LT lines went to a payer that wants a single -50 line, or the reverse. Look up the payer’s bilateral format, correct the claim, and resubmit.
• Drug code missing or J3490 invoice not provided: The payer wants invoice documentation for an unclassified drug. Submit the J3490 claim with the supplier invoice and a narrative naming the drug and dose in box 19 of the CMS-1500.
• Prior authorization not obtained: High-cost drugs given subconjunctivally, especially off-label anti-VEGF agents, may need prior authorization from some commercial and Medicare Advantage plans. Appeal with proof that authorization wasn’t required, or with a letter of medical necessity for retrospective approval.

Effective denial management workflows route each denial reason code to the right staff member and log the outcome. That record lets you fix root causes instead of working denials claim by claim.

How claims management software catches 68200 errors before submission

The 68200 errors in this guide share one trait. Someone keyed a field by hand, such as the J-code units, the eye modifier, or the diagnosis, and nobody checked it until the denial arrived.

Pabau, the practice management and billing platform we build, checks that work before the claim leaves. Its claims management software scrubs each claim for missing or invalid details. Problem claims are marked “Needs action,” so your biller fixes them first.

Eligibility checks confirm the patient’s coverage before the appointment, so a lapsed plan shows up before the drug is drawn. Claims then go out through Claim.MD, our clearinghouse partner, which connects Pabau to thousands of US payers.

Catch 68200 claim errors before submission

Pabau’s claims management scrubs each claim for missing or invalid details and flags it before it goes out. Your team fixes the claim once, before the payer sees it.

Book a demo

Conclusion

Billing 68200 cleanly starts with the note, not the claim form. When the note names the subconjunctival space, the eye, the drug and the dose, the code, the modifier and the J-code units follow from it.

The trade-off is an afternoon spent on the injection template and the claim template. That time pays back on every injection claim, because the denial reasons in this guide stop at the front desk.

Book a demo to see how Pabau’s claim scrubbing flags missing or invalid details on your injection claims before they reach the payer.

Continue your research

Need to understand how clearinghouse submission works for ophthalmology codes? Pabau’s Claim.MD clearinghouse guide explains how electronic claim routing, real-time eligibility, and ERA processing work together to reduce denials.

Looking for a primer on the ERA process after payment posts? Electronic remittance advice explained covers how to read ERA files, reconcile payments, and identify denial reason codes from CARC descriptions.

Want to reduce denial backlogs across your ophthalmology billing team? Denial codes in medical billing provides a reference guide to common CARC and RARC denial codes with resolution steps.

Injecting preservative-free triamcinolone? HCPCS code J3300 covers the per-milligram code and how to count its units.

Using methylprednisolone acetate for the injection? HCPCS code J1040 covers the 80 mg drug code billed alongside 68200.

Frequently asked questions